Neurocrine Biosciences (NBIX) Convertible Debt (2017 - 2023)
Neurocrine Biosciences (NBIX) recorded Convertible Debt of $169.5 million in Q1 2023, down 55.1% from $377.7 million a year earlier.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Convertible Debt (2017 - 2023) Analysis & Trends
At the end of FY2021, Neurocrine Biosciences reported Convertible Debt of $335.1 million, up 5.4% from FY2020.
- Annual Convertible Debt has a four-year compound annual growth rate of -2.4% (FY2017 to FY2021).
- Across earlier years, Convertible Debt came in at $317.9 million in FY2020 (-22.2%), $408.8 million in FY2019 (+5.2%), $388.5 million in FY2018 (+5.1%) and $369.62 million in FY2017.
- Quarterly Convertible Debt has ranged from $169 million in Q2 2022 to $414.1 million in Q1 2020 over the past five years.
- On a year-over-year basis, Convertible Debt rose in two of the last four quarters, with an average decline of 20.2%.
- Peak year-over-year performance for Convertible Debt in the last five years was growth of 17.3% in Q1 2022, against a decline of 55.1% in Q1 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 169.50 Mn |
| Jun 30, 2022 | 169.00 Mn |
| Mar 31, 2022 | 377.70 Mn |
| Dec 31, 2021 | 335.10 Mn |
| Sep 30, 2021 | 330.70 Mn |
| Jun 30, 2021 | 326.30 Mn |
| Mar 31, 2021 | 322.00 Mn |
| Dec 31, 2020 | 317.90 Mn |
| Mar 31, 2020 | 414.10 Mn |
| Dec 31, 2019 | 408.80 Mn |
| Sep 30, 2019 | 403.59 Mn |
| Jun 30, 2019 | 398.47 Mn |
| Mar 31, 2019 | 393.44 Mn |
| Dec 31, 2018 | 388.50 Mn |
| Jun 30, 2018 | 378.89 Mn |
| Mar 31, 2018 | 374.21 Mn |
| Dec 31, 2017 | 369.62 Mn |
| Sep 30, 2017 | 365.11 Mn |
| Jun 30, 2017 | 360.68 Mn |
API Access
Neurocrine Biosciences Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();